SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009401
Filing Date
2024-06-21
Accepted
2024-06-21 16:15:14
Documents
14
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20240620x8k.htm   iXBRL 8-K 85105
  Complete submission text file 0001558370-24-009401.txt   219121

Data Files

Seq Description Document Type Size
2 EX-101.SCH nxtc-20240620.xsd EX-101.SCH 4060
3 EX-101.DEF nxtc-20240620_def.xml EX-101.DEF 2850
4 EX-101.LAB nxtc-20240620_lab.xml EX-101.LAB 17906
5 EX-101.PRE nxtc-20240620_pre.xml EX-101.PRE 11816
17 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240620x8k_htm.xml XML 5032
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 241060347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)